BN Business News
Add your company to Business Communicator →

Business · 20/07/2015Updated: 10/17/2026 · 1 min read

FDA Clears TESSALON Capsules for Sale, Citing Lack of Safety or Effectiveness Concerns

Summary

The US Food and Drug Administration (FDA) has officially stated that TESSALON (Benzonatate) capsules and other listed drug products were not withdrawn from the market due to concerns over their safety or effectiveness, allowing the FDA to continue approving new applications for these products.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →